Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Hair restoration surgery can lead to swelling, infections, scarring, numbness, hiccups, and poor hair growth.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Polydeoxyribonucleotide (PDRN) may help lighten skin and treat hyperpigmentation.

Personalized treatment plans are important for people with alopecia areata.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Laser-assisted drug delivery has shown improved treatment outcomes for skin conditions and has potential to reduce side effects and treatment time.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.